Daniel Associates

Get in-depth analysis of how COVID-19 is impacting the Antihypertensive Drugs Market (Drug: Diuretics, Angiotensin Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, Beta-blockers, Vasodilators, Calcium Channel Blockers, Renin Inhibitors, Alpha-blockers, and Others; Condition: Primary Hypertension and Secondary Hypertension; Medication Type: Monotherapy, Combination Therapy, and Fixed Dose Combinations; and Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, and Others) & Region – Global Forecast to 2025

  • The Antihypertensive Drugs Market was valued at USD XX million in 2019 and is estimated to reach USD XX million by 2025, at a CAGR of XX% during the forecast period. The base year used for this study is 2019, and the forecast period considered is between 2020 and 2025.

    The objectives of the study are as follows:

    • To define, describe, and forecast the Market (Drug: Diuretics, Angiotensin Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, Beta-blockers, Vasodilators, Calcium Channel Blockers, Renin Inhibitors, Alpha-blockers, and Others; Condition: Primary Hypertension and Secondary Hypertension; Medication Type: Monotherapy, Combination Therapy, and Fixed Dose Combinations; and Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, and Others) & Region
    • To forecast the market size in terms of value for various segments with respect to five main regions: North America, Europe, APAC, Middle East & Africa and Latin America.
    • To provide detailed information regarding the major factors influencing the growth of the Antihypertensive Drugs Market (drivers, restraints, opportunities, and industry-specific challenges)
    • To analyze the opportunities in the market for various stakeholders by identifying the high-growth segments of the Antihypertensive Drugs Market
    • To strategically profile the key players and comprehensively analyze their market position in terms of ranking and core competencies, along with detailing the competitive landscape for the market leaders
    • To analyze competitive developments such as new product launches and developments; agreements and contracts; mergers and acquisitions; and expansions in the global Antihypertensive Drugs Market

    The years considered for the study are:

    Base Year – 2019         Estimated Year – 2020         Forecast Period – 2025

    For company profiles in the report, 2019 has been considered as the base year. In certain cases, wherein information is unavailable for the base year, the years prior to it have been considered.

    Scope of the Report:

    Antihypertensive Drugs Market, By Drug:
    Diuretics
    Angiotensin Converting Enzyme Inhibitors
    Angiotensin Receptor Blockers
    Beta-blockers
    Vasodilators
    Calcium Channel Blockers
    Renin Inhibitors
    Alpha-blockers
    Others

    Antihypertensive Drugs Market, By Condition:
    Primary Hypertension
    Secondary Hypertension

    Antihypertensive Drugs Market, By Medication Type:
    Monotherapy,
    Combination Therapy,
    Fixed Dose Combinations

    Antihypertensive Drugs Market, By Distribution Channel:
    Retail Pharmacies
    Hospital Pharmacies
    Online Pharmacies
    and Others

    Antihypertensive Drugs Market, By Region:
    Asia-Pacific
    North America
    Europe
    Latin America
    Middle East & Africa

  • Table of Contents

    1 Introduction

    2 Research Methodology

    3 Executive Summary

    4 Premium Insights
        4.1 Attractive Opportunities in Antihypertensive Drugs Market
        4.2 Antihypertensive Drugs Market, By Drug
        4.3 Antihypertensive Drugs Market, By Condition
        4.4 Antihypertensive Drugs Market, By Medication Type
        4.5 Antihypertensive Drugs Market, By Distribution Channel
        4.6 Antihypertensive Drugs Market, By Region

    5 Market Overview
        5.1 Introduction
        5.2 Market Dynamics
               5.2.1 Drivers
               5.2.2 Restraints
               5.2.3 Opportunities
               5.2.4 Challenges

    6 Antihypertensive Drugs Market, By Drug
        6.1 Introduction
        6.2 Diuretics
        6.3 Angiotensin Converting Enzyme Inhibitors
        6.4 Angiotensin Receptor Blockers
        6.5 Beta-blockers
        6.6 Vasodilators
        6.7 Calcium Channel Blockers
        6.8 Renin Inhibitors
        6.9 Alpha-blockers
        6.10 Others

    7 Antihypertensive Drugs Market, By Condition
       7.1 Introduction
       7.2 Primary Hypertension
       7.3 Secondary Hypertension

    8 Antihypertensive Drugs Market, By Medication Type
       8.1 Introduction
       8.2 Monotherapy,
       8.3 Combination Therapy,
       8.4 Fixed Dose Combinations

    9 Antihypertensive Drugs Market, By Distribution Channel
       9.1 Introduction
       9.2 Retail Pharmacies
       9.3 Hospital Pharmacies
       9.4 Online Pharmacies
       9.5 Others

    10 Antihypertensive Drugs Market, By Region
         10.1 Introduction
         10.2 North America
         10.3 Europe
         10.4 APAC
         10.5 Middle East & Africa
         10.6 Latin America

    11 Competitive Landscape

    12 Company Profile
         12.1 Boehringer Ingelheim GmbH
         12.2 Merck KGaA
         12.3 Actelion Ltd. (Johnson & Johnson Services, Inc.)
         12.4 Bayer AG
         12.5 Pfizer, Inc
         12.6 Takeda Pharmaceutical Co., Ltd.
         12.7 AstraZeneca plc
         12.8 Daiichi Sankyo Company
         12.9 Sanofi S.A.
         12.10 Novartis International AG.
         12.11 Lupin
         12.12 Sun Pharmaceutical Industries Ltd. (Ranbaxy Laboratories)
         12.13 F. Hoffmann-La Roche Ltd.

    (Business Overview, Products & Services, Recent Developments, Financials)*
    *Details Might Not Be Captured in Case of Unlisted Companies.



  • Select User License